MAPT and supranuclear palsy, progressive, 1: PSP is a mainly sporadic 4R tauopathy, with familial cases making up less than 5% of affected patients. Genetic variations (such as the H1 and H2 haplotype, which will be discussed in further detail below) within the MAPT gene were suggested to confer increased risk for PSP [47, 48].